# Abaloparatide bone biopsy study: bone formation at 3 months

Source: https://pepvault.app/research/abaloparatide-dempster-2021

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Abaloparatide](https://pepvault.app/research#abaloparatide)

Clinical trial · people

# Abaloparatide: bone formation up on every surface tested at 3 months

Checked against the paper November 2026 Clinical trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

Abaloparatide started measurable new bone formation across every bone surface studied within 3 months, through both remodeling and modeling, though this study does not show a fracture benefit on its own.

- **Kind:** Clinical trial
- **Studied in:** People
- **Number studied:** 23
- **Published:** 2021
- **Journal:** J Bone Miner Res

## What they tested

The team wanted to see how early abaloparatide starts new bone formation, and whether that new bone comes from remodeling, modeling or both.

## How the study was done

An open-label, single-arm study in 23 postmenopausal women with osteoporosis, all given the trial's 80 μg daily dose with no control group. Bone-labeling dyes were given before treatment and again before a transiliac bone biopsy at 3 months, so changes from baseline could be measured.

<!--promo-->

PepVault for iPhone

## Taking abaloparatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

After 3 months, median mineralizing surface, a measure of how much bone surface is actively forming, rose to 24.7%, 48.7%, 21.4% and 16.3% of total surface. Those were 5.5-, 5.2-, 2.8- and 12.9-fold changes on the cancellous (spongy inner bone), endocortical (inner face of the outer shell), intracortical (inside the shell) and periosteal (outer face) surfaces, each a significant rise over baseline. Bone formation rate went up on every surface measured, while mineral apposition rate went up only on intracortical surfaces. Modeling-based formation, meaning new bone laid down without first being broken down, made up 37% of the rise in bone-forming surface on endocortical bone and 23% on cancellous bone, and blood markers of bone turnover at month 1 or month 3 generally tracked the biopsy changes.

## What it doesn’t show

This was a small, open-label study with no comparison group and only 3 months of treatment. It measured bone formation in biopsies, not fractures or bone density.

## The paper

Dempster et al. Early Effects of Abaloparatide on Bone Formation and Resorption Indices in Postmenopausal Women With Osteoporosis. J Bone Miner Res. 2021.

- [PubMed (PMID 33434314)](https://pubmed.ncbi.nlm.nih.gov/33434314/)
- [The paper (DOI 10.1002/jbmr.4243)](https://doi.org/10.1002/jbmr.4243)
- [ClinicalTrials.gov (NCT03710889)](https://clinicaltrials.gov/study/NCT03710889)

## The compound

- [Abaloparatide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/abaloparatide)
- [Abaloparatide dose guide](https://pepvault.app/lab/dosage/abaloparatide)

## With this study

### Abaloparatide

- [Abaloparatide: the full reference](https://pepvault.app/peptides/abaloparatide)
- [Abaloparatide dose guide](https://pepvault.app/lab/dosage/abaloparatide)

### Studies

- [Abaloparatide, teriparatide beat other drugs on spine BMD in men](https://pepvault.app/research/abaloparatide-chen-2025)
- [Abaloparatide: larger hip BMD gains than teriparatide at 24 weeks](https://pepvault.app/research/abaloparatide-hong-2023)
- [Abaloparatide raised hip BMD around a virtual hip stem in ACTIVE](https://pepvault.app/research/abaloparatide-active-2024)
- [All 8 studies](https://pepvault.app/research#abaloparatide)

### Compared with

- [Teriparatide vs Abaloparatide](https://pepvault.app/peptides/compare/teriparatide-vs-abaloparatide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Open-label](https://pepvault.app/glossary/open-label)

## More studies on Abaloparatide

- [Abaloparatide, teriparatide beat other drugs on spine BMD in men](https://pepvault.app/research/abaloparatide-chen-2025) Meta-analysis · people · 2025
- [Abaloparatide: larger hip BMD gains than teriparatide at 24 weeks](https://pepvault.app/research/abaloparatide-hong-2023) Meta-analysis · people · 2023
- [Abaloparatide raised hip BMD around a virtual hip stem in ACTIVE](https://pepvault.app/research/abaloparatide-active-2024) Randomized trial · people · 2024
- [Abaloparatide improved hip geometry vs placebo in ACTIVE-J](https://pepvault.app/research/abaloparatide-active-j-2023) Randomized trial · people · 2023
- [Abaloparatide then alendronate: 84% lower vertebral fracture risk](https://pepvault.app/research/abaloparatide-activextend-2018) Randomized trial · people · 2018
- [Abaloparatide: normal bone biopsies after up to 18 months in ACTIVE](https://pepvault.app/research/abaloparatide-active-2017) Randomized trial · people · 2017
- [Every study on Abaloparatide](https://pepvault.app/research#abaloparatide)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking abaloparatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking abaloparatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Abaloparatide

- [Abaloparatide: the full reference](https://pepvault.app/peptides/abaloparatide)
- [Abaloparatide dose guide](https://pepvault.app/lab/dosage/abaloparatide)

### Studies

- [Abaloparatide, teriparatide beat other drugs on spine BMD in men](https://pepvault.app/research/abaloparatide-chen-2025)
- [Abaloparatide: larger hip BMD gains than teriparatide at 24 weeks](https://pepvault.app/research/abaloparatide-hong-2023)
- [Abaloparatide raised hip BMD around a virtual hip stem in ACTIVE](https://pepvault.app/research/abaloparatide-active-2024)
- [All 8 studies](https://pepvault.app/research#abaloparatide)

### Compared with

- [Teriparatide vs Abaloparatide](https://pepvault.app/peptides/compare/teriparatide-vs-abaloparatide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Open-label](https://pepvault.app/glossary/open-label)

<!--promo-->

PepVault for iPhone

## Taking abaloparatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Abaloparatide](https://pepvault.app/research#abaloparatide)

## The library

- [Abaloparatide](https://pepvault.app/peptides/abaloparatide)
- [Abaloparatide dose guide](https://pepvault.app/lab/dosage/abaloparatide)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
